Emily Cowley Leongini’s Perspectives

124 total results. Page 9 of 11.

Alerts
Consumer Groups File False Advertising Suit Over ‘100% Natural’ Claim, Alleging Residues in Poultry
Alerts
How FDA’s Program Alignment Initiative Will Impact Industries: An Insider’s Perspective
News
Emily Leongini Featured in Q&A with Marijuana Business Daily
Alerts
Media Investigations into Integrity of Organic Program Growing
Alerts
Cannabis Industry Standards: ASTM Considers Filling the Void
Alerts
Recent Drug Company Settlement Highlights Unique Theory of False Claims Act Liability: Failure to Follow Current Good Manufacturing Practices
Health Care Counsel Blog
Recent Drug Company Settlement Highlights Unique Theory of False Claims Act Liability: Failure to Follow Current Good Manufacturing Practices
Alerts
Trump’s 2-for-1 Executive Order, its Impact on FDA, and the Significance of “Significant”
Health Care Counsel Blog
FDA Finalizes Guidance on Assessing New Drug Abuse Potential
News
Emily Leongini Featured in Interview on FDA’s Role in the Cannabis Industry
Health Care Counsel Blog
The Secret's Out: FDA Allows Drug and Device Manufacturers to Share HCEI Prior to Product Approval
Alerts
USDA and FDA Issue Proposals to Regulate Genome Edited Plants, Animals, and Microorganisms